Vermillion, Inc. (VRML) has released financial data pertaining to their first quarter results for 2013; these numbers include the results as of March 31, 2013. The company is based in Austin, Texas, and specializes in molecular diagnostics that focus on women’s health and especially gynecological cancers.
http://bionews-tx.com/news/2013/05/16/austin-based-vermillion-announces-first-quarter-2013-results-and-future-plans/
No comments:
Post a Comment